EVIDENT and Ultivue: Collaboration provides a convenient, fast tool for multiplexed immunofluorescence imaging in translational studies. WALTHAM and CAMBRIDGE, Mass., (Nov. 7, 2022)–Evident Corporation, a

Queen Mary University of London has become the first university outside of North America to acquire a Cell DIVE imager, providing access to the latest

by Tim Scherr, Johannes Seiffarth, Bastian Wollenhaupt, Oliver Neumann, Marcel P. Schilling, Dietrich Kohlheyer, Hanno Scharr, Katharina N?h, Ralf Mikut In biotechnology, cell growth is

Pixelgen Technologies has emerged from stealth with a mission to bring a new dimension to single-cell spatial proteomics. The launch follows the close of an